The Protective Effect of Adalimumab on Renal Injury in a Model of Abdominal Aorta Cross-Clamping

Cure M. C. , Cure E., Kalkan Y., Tumkaya L. , Aydin I. , Kirbas A., ...Daha Fazla

ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE, cilt.25, sa.2, ss.219-226, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 25 Konu: 2
  • Basım Tarihi: 2016
  • Doi Numarası: 10.17219/acem/33250
  • Dergi Adı: ADVANCES IN CLINICAL AND EXPERIMENTAL MEDICINE
  • Sayfa Sayıları: ss.219-226

Özet

Background. Adalimumab (ADA) is a potent inhibitor of tumor necrosis factor (TNF-alpha). ADA treatment suppresses proinflammatory cytokines, leading to a decrease or inhibition of the inflammatory process.